Hanmi Pharmaceutical

Hanmi Pharmaceutical

14 Wiryeseong-daero, Seoul, Seoul, South Korea

Rosuzet tab.

Rosuzet tab.

Rosuzet tab.

  • Category[ETC] Cardiovascular
  • FeaturesDual action
    LDL-C reduction effectiveness
    No additional side effects against single treatment
  • IndicationPrimary hypercholesterolemia
    Ezetimibe + Rosuvastatin
  • Active IngredientEzetimibe + Rosuvastatin
  • Strength10/5mg
    10/10mg
    10/20mg
  • Packing30tab
  • LaunchedLaunched(2015.4Q)

 

  Technical Specs
Other Products

Product Enquiry

SSL Secure Connection